Prevalence and Associated Predictors of Inappropriate and Omitted Medications Prescribing in Older Patients with Advanced Cancer: A Cross-Sectional Study.

In concordance with published studies, polypharmacy was a highly significant independent predictor for reporting a greater number of PIMs and adverse treatment outcomes in older patients with and without cancer. 3 , 16 , 31 Higher odds in PIMs due to differences in type of cancer (solid vs hematological) might be explained by the higher prevalence of solid tumors collectively compared to hematological cancer among geriatric populations.

also in 132,142 other papers